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Original Article

Time to Treatment and Mortality
during Mandated Emergency Care for Sepsis
Christopher W. Seymour, M.D., Foster Gesten, M.D., Hallie C. Prescott, M.D.,
Marcus E. Friedrich, M.D., Theodore J. Iwashyna, M.D., Ph.D.,
Gary S. Phillips, M.A.S., Stanley Lemeshow, Ph.D., Tiffany Osborn, M.D., M.P.H.,
Kathleen M. Terry, Ph.D., and Mitchell M. Levy, M.D.

A BS T R AC T
BACKGROUND

In 2013, New York began requiring hospitals to follow protocols for the early
identification and treatment of sepsis. However, there is controversy about whether
more rapid treatment of sepsis improves outcomes in patients.
METHODS

We studied data from patients with sepsis and septic shock that were reported to
the New York State Department of Health from April 1, 2014, to June 30, 2016.
Patients had a sepsis protocol initiated within 6 hours after arrival in the emergency department and had all items in a 3-hour bundle of care for patients with
sepsis (i.e., blood cultures, broad-spectrum antibiotic agents, and lactate measurement) completed within 12 hours. Multilevel models were used to assess the associations between the time until completion of the 3-hour bundle and risk-adjusted
mortality. We also examined the times to the administration of antibiotics and to
the completion of an initial bolus of intravenous fluid.
RESULTS

Among 49,331 patients at 149 hospitals, 40,696 (82.5%) had the 3-hour bundle
completed within 3 hours. The median time to completion of the 3-hour bundle
was 1.30 hours (interquartile range, 0.65 to 2.35), the median time to the administration of antibiotics was 0.95 hours (interquartile range, 0.35 to 1.95), and the
median time to completion of the fluid bolus was 2.56 hours (interquartile range,
1.33 to 4.20). Among patients who had the 3-hour bundle completed within 12
hours, a longer time to the completion of the bundle was associated with higher
risk-adjusted in-hospital mortality (odds ratio, 1.04 per hour; 95% confidence interval [CI], 1.02 to 1.05; P<0.001), as was a longer time to the administration of
antibiotics (odds ratio, 1.04 per hour; 95% CI, 1.03 to 1.06; P<0.001) but not a
longer time to the completion of a bolus of intravenous fluids (odds ratio, 1.01 per
hour; 95% CI, 0.99 to 1.02; P = 0.21).

From the Departments of Critical Care
Medicine and Emergency Medicine, University of Pittsburgh School of Medicine,
and the Clinical Research, Investigation,
and Systems Modeling of Acute Illness
(CRISMA) Center — both in Pittsburgh
(C.W.S.); the New York State Department
of Health, Albany (F.G., M.E.F.), and
IPRO, Lake Success (G.S.P., K.M.T.) —
both in New York; the University of Michigan and the Veterans Affairs Center for
Clinical Management Research — both
in Ann Arbor (H.C.P., T.J.I.); the Division
of Biostatistics, Ohio State University
College of Public Health, Columbus
(S.L.); Washington University, St. Louis
(T.O.); and the Warren Alpert Medical
School at Brown University, Providence,
RI (M.M.L.). Address reprint requests to
Dr. Seymour at the Departments of Critical Care Medicine and Emergency Medicine, University of Pittsburgh School of
Medicine, 3550 Terrace St., Scaife Hall,
Rm. 639, Pittsburgh, PA 15261, or at
seymourcw@upmc.edu.
This article was published on May 21,
2017, at NEJM.org.
N Engl J Med 2017;376:2235-44.
DOI: 10.1056/NEJMoa1703058
Copyright © 2017 Massachusetts Medical Society.

CONCLUSIONS

More rapid completion of a 3-hour bundle of sepsis care and rapid administration
of antibiotics, but not rapid completion of an initial bolus of intravenous fluids,
were associated with lower risk-adjusted in-hospital mortality. (Funded by the
National Institutes of Health and others.)
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ore than 1.5 million cases of sepsis occur in the United States annually,
and many patients with sepsis present
to the emergency department.1 International
clinical practice guidelines and the Centers for
Medicare and Medicaid Services (CMS) recommend the prompt identification of sepsis and
treatment with broad-spectrum antibiotic agents
and intravenous fluids.2,3 These recommendations are supported by preclinical and observational studies suggesting that early treatment
with antibiotics and intravenous fluids could reduce the number of avoidable deaths.4,5
Yet, considerable controversy exists about how
rapidly sepsis must be treated.6 Some clinicians
question the potential benefit of rapid treatment, citing the absence of data from randomized trials, the potential for adverse effects, and
the challenging implementation of these efforts
in environments where staff are often overworked. Using data from New York,7 where hospitals are required to implement protocols and
report on the treatment of sepsis, we examined
the association between the timing of treatment
and risk-adjusted mortality.

m e dic i n e

Appendix, available with the full text of this article at NEJM.org.
We performed a retrospective study involving
185 hospitals in the NYSDOH database, including data from April 1, 2014, to June 30, 2016. All
the hospitals were required to report patientlevel data for patients with sepsis and septic
shock to the Department of Health using electronic case-report forms that included data on
demographic characteristics, coexisting conditions, characteristics of sepsis and septic shock,
illness severity, and outcomes. Date and time
stamps for protocol initiation and the elements
of 3-hour and 6-hour bundled care were required
for patients in whom a sepsis protocol was initiated. The state performed audits on a 10% random sample of hospitals using manual chart
review and provided feedback to hospitals regarding data quality and completeness. Audit
results are provided in Table S2 in the Supplementary Appendix. Patient-level data were linked
to hospital characteristics with the use of the
NYSDOH administrative database. This study was
approved with a waiver of informed consent by
the NYSDOH institutional review boards.
Selection of Patients

Me thods
Study Design and Population

In early 2013, the New York State Department of
Health (NYSDOH) began requiring hospitals to
submit and follow evidence-informed protocols
for the early identification and treatment of severe
sepsis or septic shock (New York Codes, Rules,
and Regulations parts 405.2 and 405.4). Although
protocols could be tailored by each hospital, all
the protocols were required to include a 3-hour
bundle consisting of receipt of the following
care within 3 hours: obtaining of a blood culture
before the administration of antibiotics, measurement of the serum lactate level, and the administration of broad-spectrum antibiotics. Protocols
were also required to include a 6-hour bundle,
consisting of the administration of a bolus of
30 ml of intravenous fluids per kilogram of body
weight in patients with hypotension or a serum
lactate level of 4.0 mmol or more per liter, the
initiation of vasopressors for refractory hypotension, and the remeasurement of the serum lactate
level within 6 hours after the initiation of the
protocol. Details about the treatment bundles
are provided in Table S1 in the Supplementary
2236
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Eligible encounters included those with patients
who were older than 17 years of age and who
had severe sepsis or septic shock, as defined
with the use of criteria suggested in the 2001
International Sepsis Definitions Conference
(Sepsis-2).8 In order to study only patients with
community-acquired sepsis, we focused on patients who had a sepsis protocol initiated in the
emergency department within 6 hours after arrival
at the hospital. To remove outliers, we excluded
patients in whom the 3-hour bundle was completed more than 12 hours after the initiation of
the protocol. We also excluded patients in whom
bundled care could be clinically contraindicated,
patients with advance directives that limited
treatment, patients who declined interventions,
and patients who were enrolled in a clinical trial.
We excluded 36 hospitals that had fewer than 50
cases of sepsis in order to remove spurious findings in reliability-adjusted models.9
Hospitals varied in their sepsis-identification
strategies (see the Methods section in the Supplementary Appendix). These strategies included
positive screening for sepsis on the basis of clinical assessment only (suspected or confirmed
nejm.org
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infection and two or more criteria for the systemic inflammatory response syndrome, with
supporting laboratory test results optional); positive screening based on both clinical criteria and
abnormal laboratory values; and a “code sepsis
or rapid response” strategy that led to a positive
screening based on clinical criteria. The regulations permitted hospitals to have flexibility with
regard to case identification in order to facilitate
broad adoption. Cases were not identified with
the use of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
because these definitions were released after the
implementation of the regulations was under
way,10 and it was not possible to use post hoc
adjudication. More than 98% of the patients with
data entered in the database were confirmed to
have had severe sepsis or septic shock on manual audit (Table S2 in the Supplementary Appendix). Cases that were found to have been entered
erroneously could be removed by hospitals.
Variables

The primary outcome was in-hospital mortality.
The primary exposure was the time to completion of the 3-hour bundle, which was defined as
the time in hours from the initiation of the
protocol until all the elements of the 3-hour
bundle were performed (i.e., blood cultures obtained, broad-spectrum antibiotics administered,
and serum lactate level measured). If any element of the 3-hour bundle was performed before
the start of the protocol, the patient was considered to have adhered to the protocol with regard
to that element within the first hour. The time to
the administration of broad-spectrum antibiotics was defined in a similar fashion. The time to
the completion of the initial bolus of intravenous fluid was measured as the time from the
initiation of the protocol until the completed
administration of 30 ml of crystalloid fluid per
kilogram, but only among patients who had a
serum lactate level of 4.0 mmol or more per liter
or who had hypotension (systolic blood pressure,
<90 mm Hg).
Covariates included variables that were specified a priori as potential confounders between
time to treatment and outcome on the basis of
clinical experience and previous studies.10,11 These
variables included demographic factors such as
age, race or ethnic group, payer, burden of coexisting conditions, site of infection (e.g., respiran engl j med 376;23

tory, urinary, or skin), admission source (e.g.,
clinic, skilled nursing facility, or home), and
measures of illness severity such as the presence
of shock, serum lactate level, platelet count, or
mechanical ventilation at admission. We developed a risk-adjustment model for in-hospital
mortality using the above covariates with multivariable logistic regression that included a 90%
random sample of the cohort. Internal validation
of the model on the 10% remaining sample revealed adequate calibration (Hosmer–Lemeshow
goodness-of-fit test with group size of 150,
P = 0.97) (Fig. S2 in the Supplementary Appendix) and discrimination (area under the receiveroperating-characteristic curve [C statistic], 0.77).
Sensitivity Analyses

We assessed the robustness of our analyses by
repeating the primary analysis using the time to
treatment as measured from the earliest recorded time of the presentation in the emergency
department.6 We also assessed models in prespecified subgroups of patients. We repeated
models with the subgroup of patients who had a
protocol initiated up to 24 hours after arrival in
the emergency department and with the subgroup of patients who had up to 24 hours between protocol initiation and completion of the
3-hour bundle.12 We repeated models with patients who were discharged to hospice care classified as dead at discharge and models that excluded any patients who had an element of the
3-hour bundle, administration of antibiotics, or
completion of bolus of intravenous fluids before
protocol initiation.
In supporting analyses, we measured the association of other elements of the 3-hour bundle
with mortality, including the time to obtaining
of a blood culture and the time to serum lactate
measurement. We performed quantitative bias
analysis to assess the magnitude of a hypothetical, unmeasured confounder that would be necessary to account for the association between
the time to completion of the 3-hour bundle and
risk-adjusted in-hospital mortality (see the Supplementary Appendix).13
Statistical Analysis

We performed bivariate analyses of the characteristics of the patients who had the 3-hour
bundle in the emergency department completed
within 3 hours and those who did not have the
nejm.org
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3-hour bundle completed within that time window. Continuous data are expressed as means
with standard deviations or as medians with
interquartile ranges, depending on normality.
Categorical variables are shown as proportions.
The range and variability in the times to treatments are shown with the use of histograms and
cumulative proportions.
Multivariable modeling of the association between the time to treatment and in-hospital
mortality was performed with the use of logistic
regression, with adjustment for covariates. Binary variables were modeled as indicator covariates, and continuous variables were included as
linear covariates, after assessment for nonlinear
relationships with the use of fractional polynomials (P>0.05 for all models).14 We used multilevel regression with a random effect of hospital
to account for hospital-level clustering. Each exposure (i.e., time to completion of the 3-hour
bundle, time to the administration of broadspectrum antibiotics, and time to completion of
initial bolus of intravenous fluids) was evaluated

Cumulative Probability

1.0

0.8

0.6

0.4
3-Hr bundle completed

0.2

0.0

Broad-spectrum antibiotics administered
Initial intravenous-fluid bolus completed
1

2

3

4

5

6

7

8

9

10 11 12

Time after Protocol Initiation (hr)

Figure 1. Cumulative Probability of Completion of
the 3-Hour Bundle, Administration of Broad-Spectrum
Antibiotics, and Completion of the Initial IntravenousFluid Bolus after the Time That the Sepsis Protocol
Was Initiated.
The 3-hour bundle for the care of patients with sepsis
or septic shock had to include receipt of the following
care within 3 hours: obtaining of a blood culture before
the administration of antibiotics, measurement of the
serum lactate level, and the administration of broadspectrum antibiotics; however, protocols could be tailored by each hospital. We also assessed the time to
the administration of broad-spectrum antibiotics and
the time to the completion of an initial bolus of intravenous fluids.
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separately. The risk of in-hospital death across
the range of time to treatment was generated for
the “typical” patient with the use of predictive
margins that were adjusted for an average of the
independent variables, as appropriate. We show
adjusted risk estimates that are derived from the
nonlinear models in order to show changes in
risk over time.14
We used empirical Bayesian methods to determine the hospital-level rate of completion of
the 3-hour bundle within 3 hours, administration
of antibiotics within 3 hours, and completion of
the initial bolus of intravenous fluids within
6 hours.9 We show the ranked order of adjusted
rates across hospitals in caterpillar plots. All the
analyses were performed with the use of Stata
software, version 14.2 (StataCorp).

R e sult s
Population of Patients and Time to Treatment

Of 111,816 patients at 185 hospitals, we excluded 21,046 patients (18.8%) who were ineligible,
32,665 (29.2%) who had protocols initiated outside the emergency department, 3648 (3.3%)
who had protocols initiated after 6 hours, and
5126 (4.6%) who did not have the 3-hour bundle
completed within 12 hours (Fig. S1 and Table S3
in the Supplementary Appendix). Of the remaining 49,331 eligible patients in the emergency
department at 149 hospitals, most (40,696 patients [82.5%]) had the 3-hour bundle completed
within 3 hours.
The median time to the completion of the
3-hour bundle was 1.30 hours (interquartile
range, 0.65 to 2.35), the median time to the administration of broad-spectrum antibiotics was
0.95 hours (interquartile range, 0.35 to 1.95),
and the median time to the completion of the
initial bolus of intravenous fluids was 2.56
hours (interquartile range, 1.33 to 4.20) (Fig. 1).
The characteristics of the patients who had the
3-hour bundle completed within 3 hours were
similar to those who had the bundle completed
during hours 3 through 12 (Table 1, and Table
S4 in the Supplementary Appendix).
Primary Analyses

In a multivariable model, each hour of time to
the completion of the 3-hour bundle was associated with higher mortality (odds ratio of death
until completion of 3-hour bundle, 1.04 per
hour; 95% confidence interval [CI], 1.02 to 1.05;
nejm.org
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Table 1. Characteristics of the Patients.
Characteristic

Percentage of patients

All Patients
(N = 49,331)

3-Hr Bundle Completed in 3 Hr
Yes
(N = 40,696)

No
(N = 8635)

82.5

17.5

100.0

Age at admission — yr
Median

73

73

71

61–84

59–82

23,634 (47.9)

19,157 (47.1)

4477 (51.8)

White

33,075 (67.0)

27,605 (67.8)

5470 (63.3)

Female sex — no. (%)

—
<0.001

60–83

Interquartile range

P Value*

Race — no. (%)†

<0.001
<0.001

Black

8,269 (16.8)

6,487 (15.9)

1782 (20.6)

Asian

2,167 (4.4)

1,774 (4.4)

393 (4.6)

Other

5,820 (11.8)

4,830 (11.9)

990 (11.5)

4,851 (9.8)

4,022 (9.9)

829 (9.6)

0.39

5,738 (11.6)

4,656 (11.4)

1082 (12.5)

0.004

Hispanic ethnic group — no. (%)†
Coexisting condition — no. (%)
Chronic respiratory failure
Congestive heart failure

10,092 (20.5)

8,311 (20.4)

1781 (20.6)

0.67

End-stage renal disease

5,207 (10.6)

4,109 (10.1)

1098 (12.7)

<0.001

Home

33,464 (67.8)

27,306 (67.1)

6158 (71.3)

Skilled nursing facility

13,233 (26.8)

11,247 (27.6)

1986 (23.0)

2,634 (5.3)

2,143 (5.3)

491 (5.7)

Admission source — no. (%)

Other‡

<0.001

Site of infection — no. (%)

<0.001

Urinary

13,439 (27.2)

10,963 (26.9)

2476 (28.7)

Respiratory

19,839 (40.2)

16,806 (41.3)

3033 (35.1)

Gastrointestinal
Other§
Positive blood cultures — no. (%)

4,649 (9.4)

3,580 (8.8)

1069 (12.4)

11,404 (23.1)

9,347 (23.0)

2057 (23.8)

14,574 (29.5)

12,322 (30.3)

2252 (26.1)

Serum lactate — mmol/liter
Median
Interquartile range

<0.001
<0.001

2.7

2.8

2.5

1.7–4.4

1.8–4.4

1.6–4.1

Septic shock — no. (%)

22,336 (45.3)

18,393 (45.2)

3943 (45.7)

0.43

Teaching facility — no. (%)

40,257 (81.6)

7,739 (19.0)

7300 (84.5)

<0.001

In-hospital death — no. (%)

11,251 (22.8)

9,213 (22.6)

2038 (23.6)

0.05

*	P values are based on Pearson’s chi-square test for categorical variables and the Wilcoxon rank-sum test for continuous
variables.
†	Race and ethnic group were determined from medical records.
‡	Other locations include clinic or unknown.
§	Other site of infection includes skin, central nervous system, and unknown.

P<0.001) (Fig. 2, and Table S5 in the Supplementary Appendix). Patients who had the bundle
completed during hours 3 through 12 had 14%
higher odds of in-hospital death than patients in
whom all three items in the 3-hour bundle were
n engl j med 376;23

completed in 3 hours (odds ratio, 1.14; 95% CI,
1.07 to 1.21; P<0.001). The association between
the time to the administration of antibiotics and
in-hospital mortality was similar (odds ratio of
death until antibiotics were administered, 1.04
nejm.org
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Subgroup
All patients
Sex
Male
Female
Vasopressor use
Yes
No
Admission source
Home
Other
Coexisting condition
Congestive heart failure
Hemodialysis
Chronic respiratory failure
Site of infection
Respiratory
Urinary
Other
Bacteremia
Gram positive
Gram negative
Other
None

n e w e ng l a n d j o u r na l

No. of Patients

of
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Odds Ratio (95% CI)

49,331

1.04 (1.02–1.05)

25,689
23,634

1.04 (1.02–1.05)
1.03 (1.02–1.05)

16,721
32,610

1.05 (1.03–1.07)
1.02 (1.00–1.03)

33,464
15,867

1.04 (1.02–1.05)
1.04 (1.02–1.06)

10,092
5,207
5,738

1.06 (1.04–1.09)
1.06 (1.03–1.09)
1.06 (1.03–1.09)

19,839
13,439
16,053

1.03 (1.01–1.06)
1.03 (1.01–1.06)
1.04 (1.02–1.06)

7,175
6,431
965
34,757

1.01 (0.98–1.05)
1.05 (1.01–1.09)
1.15 (1.07–1.24)
1.03 (1.02–1.05)
1.0

In-Hospital Death
Less Likely

1.1

1.3

In-Hospital Death
More Likely

Figure 2. Risk-Adjusted Odds Ratios of In-Hospital Death in the Primary Model and Prespecified Subgroups.
Shown are odds ratios, with 95% confidence intervals, for in-hospital death for each hour that it took to complete
the 3-hour bundle. Other site of infection includes gastrointestinal, skin, central nervous system, and unknown.

per hour; 95% CI, 1.03 to 1.06; P<0.001) (Fig. S3
in the Supplementary Appendix). Patients who
received antibiotics in hours 3 through 12 had
14% higher odds of in-hospital death than those
who received antibiotics within 3 hours (odds
ratio, 1.14; 95% CI, 1.06 to 1.22; P = 0.001). These
associations appeared to be stronger among patients receiving vasopressors than among those
who were not receiving vasopressors (Fig. 2, and
Fig. S3 in the Supplementary Appendix). Figure 3
shows the crude and predicted risks of in-hospital death across a range of times to treatment in
typical patients who presented to the emergency
department. On average, the completion of the
3-hour bundle at 6 hours was associated with
mortality that was approximately 3 percentage
points higher than the mortality associated with
completion of the bundle within the first hour.
Among the 26,978 patients who were eligible
for and had the bolus of intravenous fluids completed within 12 hours, the time to completion
of the fluid bolus was not associated with in2240

n engl j med 376;23

hospital mortality (odds ratio of death until fluid
bolus was completed, 1.01 per hour; 95% CI,
0.99 to 1.02; P = 0.21) (Fig. S4 in the Supplementary Appendix). Patients who had the initial
fluid bolus completed during hours 6 through
12 had an odds of in-hospital death that was
similar to that among patients who had the initial fluid bolus completed within 6 hours (odds
ratio of death for >6 hours to complete intravenous-fluid bolus, 1.02; 95% CI, 0.92 to 1.14;
P = 0.65). We found no interaction between time
to the administration of antibiotics and time to
completion of the initial bolus of intravenous
fluids (P = 0.88).
Additional Analyses

A sensitivity analysis that used the earliest time
of arrival in the emergency department to measure the time to treatment showed an association that was similar to that in the primary
analyses. The results were unchanged when
hospice discharges were reclassified as in-hospinejm.org
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Discussion
Our findings support an association between
time to treatment and outcome among patients
with sepsis or septic shock treated in the emergency department during a statewide initiative
mandating protocolized care. We found that a
longer time to completion of a 3-hour bundle of
care for patients with sepsis and the administration of broad-spectrum antibiotics were each
n engl j med 376;23

A 3-Hr Bundle

In-Hospital Mortality (%)
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Time to Administration of Antibiotics (hr)

C Initial Bolus of Intravenous Fluids
35

In-Hospital Mortality (%)

tal deaths or when we excluded patients who had
treatments completed before protocol initiation.
When the time window for protocol initiation or
completion of the 3-hour bundle was relaxed to
24 hours, the association between completion of
the bolus of intravenous fluids and mortality
became significant, albeit of very small magnitude (odds ratio 1.001; 95% CI, 1.000 to 1.002;
P = 0.03). Details are provided in Table S6 in the
Supplementary Appendix.
In supporting analyses, we found that the
time to obtaining a blood culture was associated
with mortality (odds ratio, 1.04 per hour; 95%
confidence interval, 1.02 to 1.06; P<0.001). Similar findings were observed for each hour until
serum lactate measurement (Figs. S5 and S6 in
the Supplementary Appendix). The quantitative
bias analysis indicated that our results would
be robust unless an unmeasured confounder
was at least twice as prevalent among patients
who had the 3-hour bundle completed later as
among those who had it completed 1 hour earlier and unless the unmeasured confounder
increased the odds of in-hospital death by more
than 1.35 times (Fig. S7 in the Supplementary
Appendix).
The risk-adjusted and reliability-adjusted rates
of completing the 3-hour bundle ranged from 53
to 97% (median, 83%; interquartile range, 75 to
88) (Fig. 4, and Fig. S8 in the Supplementary
Appendix). After we ranked hospitals from the
lowest to greatest likelihood of completing the
3-hour bundle, the hospitals in the highest decile, despite similar illness severity among their
patients, were 1.5 times as likely to complete the
3-hour bundle as hospitals in the lowest decile
(94.3% vs. 64.1%). Hospitals that had a higher
rate of bundle completion within 3 hours were
somewhat smaller and less likely to be teaching
hospitals than those that took longer than 3
hours to complete the bundle (Table S7 in the
Supplementary Appendix).

Crude
Risk adjusted

30

25

20
5
0

0

1

2

3

4

5

6

7

8

9 10 11 12

Time to Completion of Bolus (hr)

Figure 3. Crude In-Hospital Mortality and Predicted Risks
of In-Hospital Death.
Shown are the crude in-hospital mortality and predicted
risks of in-hospital death, with adjustment for covariates
across a range of time after protocol initiation, for the
completion of the 3-hour bundle of sepsis care (Panel A),
the administration of broad-spectrum antibiotics (Panel B),
and the completion of the initial bolus of intravenous
fluids (Panel C) in a typical patient. I bars represent 95%
confidence intervals.
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Figure 4. Reliability-Adjusted Rate for Each Hospital for Completion
of the 3-Hour Bundle in 3 Hours, According to Hospital Rank.
The 149 hospitals that were included in the study were ranked from lowest to
highest, with higher numbers indicating a greater likelihood of completing
the 3-hour bundle within 3 hours. I bars represent 95% confidence intervals.

associated with higher risk-adjusted in-hospital
mortality. In our primary analysis, we did not
find an association between the time to completion of the initial bolus of intravenous fluids and
in-hospital mortality. The time to treatment
varied widely across hospitals.
Our findings are consistent with multiple
smaller, observational studies.5,15,16 A recent metaanalysis of 11 observational studies, however,
showed no significant mortality benefit of the
administration of antibiotics within 3 hours, as
compared with after 3 hours, after triage in the
emergency department (odds ratio, 1.16; 95% CI,
0.92 to 1.46) or within 1 hour after the recognition of shock (odds ratio, 1.46; 95% CI, 0.89 to
2.40).6 The odds ratios we report are similar, but
the confidence intervals are narrower given the
much larger sample size that was included in
our study.
This study complements a patient-level metaanalysis of goal-directed therapy in severe sepsis
and septic shock, the Protocolized Resuscitation
in Sepsis Meta-Analysis (PRISM) trial.17 More
than three of four patients in the PRISM trial
received elements of the 3-hour bundle before
2242
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randomization, after which the various trials
composing the PRISM trial tested whether protocolized resuscitation strategies improved outcomes.
Our study asked a different question: does timing
matter for these earliest and most basic elements
of care? These population-level data also place in
context the relatively high compliance with these
steps in the control groups of the various trials
composing the PRISM trial before randomization. Only half the hospitals in the statewide
database performed near this level.
There are several biologic explanations for
the association between the time to completion
of a 3-hour treatment bundle and outcome. First,
more rapid administration of antibiotics reduces
pathogen burden, modifies the host response,
and could reduce the incidence of subsequent
organ dysfunction. Second, clinicians who decide more quickly to measure the serum lactate
level may identify heretofore unrecognized shock
and are more prepared to deliver lactate-guided
resuscitation than clinicians who are slower to
measure the serum lactate level — a strategy
that may improve outcome in randomized trials.18
Third, physicians have broad variation in how
they identify sepsis, even when they are presented with similar cases.19 Fast delivery of sepsis treatment, even within the structure of mandated protocols, requires a prompt clinical
suspicion of both infection and worsening organ
dysfunction.
Although we found no association between
the time to completion of the initial bolus of
intravenous fluids and outcome in our primary
analysis, these data should not be interpreted
as evidence in favor of abandoning early fluid
resuscitation. The analysis of the time to completion of the initial fluid bolus is most prone to
confounding by indication (e.g., sicker patients
will receive fluids sooner and are also more
likely to die).20 A greater volume of fluids given
at rapid pace may also contribute to adverse effects such as pulmonary edema, volume overload, and longer duration of organ support in
selected patients.21 Causal inference will require
investigation in randomized clinical trials, and
our analysis contributes to the clinical equipoise
needed for such trials.
We found a variation of 1 to 2 times across
hospitals with regard to the rates of completing
the 3-hour bundle, the administration of antibiotics, and the completion of a bolus of intranejm.org
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venous fluids in the emergency department. Adherence, in general, ranged from 60 to 90%, and
was greater than in comparable quality-improvement programs for stroke treatment in New
York.22 Such performance may stem from increasing public awareness and advocacy about
sepsis and national quality-improvement initiatives led by CMS.23 Adherence was greatest in the
emergency departments at smaller nonteaching
hospitals, a finding that differs from a previous
cohort study.24 These hospitals may have fewer
clinicians to train, a lower census in the emergency department, and a different case mix as
compared with larger referral centers, which
perhaps facilitates the more rapid implementation of sepsis protocols.
Our study has several limitations. First, this
was not a randomized trial, so the results may
be biased by confounding. Of greatest concern
may be the lack of data about the appropriateness of broad-spectrum antibiotics. The appropriateness of the initial choice of an antibiotic
agent has been associated with risk-adjusted mortality25 but may be measurable only in the minority of patients with positive cultures and may
differ according to local pathogen and anti
microbial resistance profiles. The hospitals included in this study were limited to a single state
that may have epidemiologic features of sepsis
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